Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Background: Systematic reviews of health economic evaluations are key for evidence-based decisions but lack standardised reporting. This project aims to develop a Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) extension for systematic reviews of health economic evaluations (PRISMA-EconEval). Methods: Project stages include the following: (1) scoping review, (2) Delphi surveys, (3) consensus meeting, (4) piloting, and (5) finalisation and dissemination. The project is overseen by the international multidisciplinary PRISMA-EconEval Management Group (PMG), Advisory Group, and Patient and Public Involvement Group. The scoping review aims to identify candidate reporting items, with the protocol published elsewhere. The global applicability of these items to systematic reviews of health economic evaluations will be evaluated using sample papers from the scoping review, supplemented by nominations from the health economics community or other sources, where necessary. A multi-round online Delphi survey will be conducted to achieve consensus on items for inclusion. A purposive sample of panellists (approximately 200) will be selected, ensuring representation of the following: health economists, systematic reviewers, information specialists, guideline developers, journal editors, healthcare decision-makers, research funders, and public representatives. Across two to three rounds, panellists will use a 1–9 scale to rate each candidate item’s ability to represent the minimum required for reporting, be relevant to all systematic reviews of health economic evaluations, facilitate complete and transparent reporting, and support the quality assessment of both the review and included studies. An online consensus meeting (approximately 30 participants) will refine the wording of items and resolve any disagreements by vote. Health economists independent of the project will apply the draft guidelines to a sample of published studies and identify practical challenges. The PMG will meet to finalise the wording and presentation of the reporting items, ensure consistency with PRISMA 2020, and produce an explanation and elaboration document. Dissemination channels will include peer-reviewed health economics journals, conferences, and the EQUATOR network. Discussion: PRISMA-EconEval aims to improve clarity, consistency, transparency, quality, and overall value of systematic reviews of health economic evaluations. This will benefit researchers, peer reviewers, editors, decision-makers, and ultimately patients and the public through supporting decisions on healthcare resource allocation.

More information Original publication

DOI

10.1186/s13643-025-02911-2

Type

Journal article

Publication Date

2025-12-01T00:00:00+00:00

Volume

14